Stock AVXT AVAX TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AVAX Technologies, Inc.

Equities

AVXT

US0534953056

Market Closed - OTC Markets
Other stock markets
 03:50:54 2024-04-05 pm EDT 		5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for AVAX Technologies, Inc. -.--% -.--%
2016 Avax Technologies Announces Results of its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial in Patients with Relapsed Stage III or IV Ovarian Cancer CI
2015 AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avax Technologies Announces Results of its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial in Patients with Relapsed Stage III or IV Ovarian Cancer
CI
AVAX Technologies : Announces the Appointment of Chief Executive Officer
PR
AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer
CI
AVAX Technologies Inc. announced that it expects to receive $45 million in funding
CI
AVAX Technologies Inc. Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine Ovax
CI
AVAX TEC : AVAX Technologies, Inc. Closes Bridge Financing
PR
AVAX TECHNOLOGIES : AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVXT Stock
  4. News AVAX Technologies, Inc.